Effects of α-adrenoceptor antagonists on ABCG2/BCRP-mediated resistance and transport.

PloS One
Kohji TakaraKatsuhiko Okumura

Abstract

Acquired resistance of cancer cells to various chemotherapeutic agents is known as multidrug resistance, and remains a critical factor in the success of cancer treatment. It is necessary to develop the inhibitors for multidrug resistance. The aim of this study was to examine the effects of eight α-adrenoceptor antagonists on ABCG2/BCRP-mediated resistance and transport. Previously established HeLa/SN100 cells, which overexpress ABCG2/BCRP but not ABCB1/MDR1, were used. The effects of the antagonists on sensitivity to mitoxantrone and the transport activity of Hoehst33342, both substrates for ABCG2/BCRP, were evaluated using the WST-1 assay and cellular kinetics, respectively. ABCG2/BCRP mRNA expression and the cell cycle were also examined by real-time RT-PCR and flow cytometry, respectively. Sensitivity to mitoxantrone was reversed by the α-adrenoceptor antagonists in a concentration-dependent manner, although such effects were also found in the parental HeLa cells. Levels of ABCG2/BCRP mRNA expression were not influenced by the antagonists. The transport activity of Hoechst33342 was decreased by doxazosin and prazosin, but unaffected by the other antagonists. In addition, doxazosin and prazosin increased the proportion of S p...Continue Reading

References

Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·S M Simon, M Schindler
Apr 23, 1999·Pharmaceutical Research·R B KimG R Wilkinson
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
Jun 26, 2002·Biological & Pharmaceutical Bulletin·Kohji TakaraKatsuhiko Okumura
Sep 13, 2002·Biochimica Et Biophysica Acta·Thomas LitmanSusan E Bates
Sep 17, 2002·International Urology and Nephrology·J L Pool, R S Kirby
Mar 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kiyotaka YohAtsushi Ochiai
May 28, 2004·Expert Opinion on Pharmacotherapy·Anastasios TahmatzopoulosNatasha Kyprianou
May 12, 2006·Molecular Pharmaceutics·Yongling XiaoDavid B Duignan
Oct 6, 2007·International Journal of Cancer. Journal International Du Cancer·Hideki KandaYoshiki Sugimura
Dec 30, 2008·Advanced Drug Delivery Reviews·Kohji NoguchiYoshikazu Sugimoto
Jan 16, 2010·Nature Reviews. Cancer·Jamie I FletcherMurray D Norris
Feb 8, 2011·Toxicology·Dennis Mulac, Hans-Ulrich Humpf
May 5, 2011·The Prostate·Chun-Hou LiaoHong-Jeng Yu

❮ Previous
Next ❯

Citations

Jan 16, 2014·Journal of Experimental & Clinical Cancer Research : CR·Kazuhiro YamamotoMidori Hirai
Aug 14, 2012·Archives of Toxicology·Daniel R CioccaStuart K Calderwood

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
flow-cytometry

Software Mentioned

Modfit
Solver
Excel

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.